Physician profile
Matthew Daniel Budge
NPI 1679795876
$71,134.40
in general payments reported to CMS, 2019-2025
13 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,227 · 2020: $2,058 · 2021: $20K · 2022: $9,997 · 2023: $9,615 · 2024: $13K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $6,249 · Honoraria: $5,000 · Food and Beverage: $2,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,007.33 |
| Travel and Lodging | $6,249.26 |
| Honoraria | $5,000.01 |
| Food and Beverage | $2,942.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $56,211.40 | 2019-2025 | Catalyst Total Csr, Catalyst Csr Shoulder System, R1 Reverse Total Shoulder |
| Fx Shoulder Solutions, INC | $7,031.54 | 2024 | |
| Steelhead Surgical INC | $3,135.74 | 2019-2024 | |
| Shoulder Innovations, INC. | $1,870.93 | 2023-2024 | Inset System |
| Medacta USA, INC. | $1,222.88 | 2023 | Primary Shoulder, Amistem, Reverse Shoulder |
| Arthrex, INC. | $638.59 | 2023 | Arthroplasty Implants Anatomic Total Shoulder Eclipse, Arthrex |
| Stryker Corporation | $321.63 | 2019-2024 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Ascend Flex |
| Zimmer Biomet Holdings, INC. | $187.65 | 2022-2023 | Comprehensive |
| Checkpoint Surgical, INC | $140.79 | 2025 | Checkpoint Stimulators |
| Fh Orthopedics, INC. | $132.41 | 2021 | |
| Exactech, INC. | $127.83 | 2024 | |
| Lima USA, INC. | $75.92 | 2022 | |
| Encore Medical, LP | $37.09 | 2024 | Djo Surgical |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$118,913.89 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Budge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.